NRBO logo

NeuroBo Pharmaceuticals (NRBO)

Profile

Full Name

MetaVia Inc.

Ticker Symbol

NRBO

Exchange

NASDAQ

Country

United States

IPO

August 5, 2016

Indexes

Not included

Employees

8

Key Details

Price

-

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.46(+94.33% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name

Analyst ratings

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Dec 30, 24 HC Wainwright & Co.
Buy
May 8, 24 Maxim Group
Buy
Dec 7, 22 Ladenburg Thalmann
Buy
Feb 1, 21 HC Wainwright & Co.
Buy

Institutional Ownership

Screeners with NRBO included

No data
  • What is the ticker symbol for NeuroBo Pharmaceuticals?
  • Does NeuroBo Pharmaceuticals pay dividends?
  • What sector is NeuroBo Pharmaceuticals in?
  • What industry is NeuroBo Pharmaceuticals in?
  • What country is NeuroBo Pharmaceuticals based in?
  • When did NeuroBo Pharmaceuticals go public?
  • Is NeuroBo Pharmaceuticals in the S&P 500?
  • Is NeuroBo Pharmaceuticals in the NASDAQ 100?
  • Is NeuroBo Pharmaceuticals in the Dow Jones?
  • When was NeuroBo Pharmaceuticals's last earnings report?
  • When does NeuroBo Pharmaceuticals report earnings?
  • Should I buy NeuroBo Pharmaceuticals stock now?

What is the ticker symbol for NeuroBo Pharmaceuticals?

The ticker symbol for NeuroBo Pharmaceuticals is NASDAQ:NRBO

Does NeuroBo Pharmaceuticals pay dividends?

No, NeuroBo Pharmaceuticals does not pay dividends

What sector is NeuroBo Pharmaceuticals in?

NeuroBo Pharmaceuticals is in the Healthcare sector

What industry is NeuroBo Pharmaceuticals in?

NeuroBo Pharmaceuticals is in the Biotechnology industry

What country is NeuroBo Pharmaceuticals based in?

NeuroBo Pharmaceuticals is headquartered in United States

When did NeuroBo Pharmaceuticals go public?

NeuroBo Pharmaceuticals's initial public offering (IPO) was on August 5, 2016

Is NeuroBo Pharmaceuticals in the S&P 500?

No, NeuroBo Pharmaceuticals is not included in the S&P 500 index

Is NeuroBo Pharmaceuticals in the NASDAQ 100?

No, NeuroBo Pharmaceuticals is not included in the NASDAQ 100 index

Is NeuroBo Pharmaceuticals in the Dow Jones?

No, NeuroBo Pharmaceuticals is not included in the Dow Jones index

When was NeuroBo Pharmaceuticals's last earnings report?

NeuroBo Pharmaceuticals's most recent earnings report was on May 9, 2025

When does NeuroBo Pharmaceuticals report earnings?

The date for NeuroBo Pharmaceuticals's next earnings report has not been announced yet

Should I buy NeuroBo Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page